UBS lists predictions for Chinese stocks with high profit growth potential for next year (Table)

AASTOCKS
2025.11.18 04:42

UBS released a strategy report on the Chinese market, listing a "Buy rated" list of Chinese stocks with high potential for earnings growth next year (Buy rated names with highest potential FY26 earnings upside), including only Hong Kong stocks and Chinese concept stocks:

Stocks

InnoCare Pharma (09969.HK)

Kintor Pharmaceutical (02171.HK)

Zai Lab (09688.HK)

Akeso (09926.HK)

ECARX Holdings (ECX.US)

CanSinoBIO (06185.HK)

Zhongsheng Holdings (00881.HK)

BeiGene (ONC.US)

Li Auto (LI.US)

GDS Holdings (GDS.US)

iQIYI (IQ.US)

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.